Liang Xu

机构：University of Science and Technology of China, Zhejiang Cancer Hospital, Children's Hospital of Zhejiang University, Zhejiang Institute of Mechanical and Electrical Engineering, Zhejiang University · ORCID：0000-0002-2700-4840

发表论文 182 篇 · 总被引 5727 次 · h-index 40

代表论文

• Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trial (2025 · BMJ · 被引 35)
• Defect-Engineered WO 3– x Architectures Coupled with Random Forest Algorithm Enables Real-Time Seafood Quality Assessment (2024 · ACS Sensors · 被引 26)
• Artemisinin alleviates ischemic stroke injury and promotes neurogenesis through PPARγ-mediated M2 polarization of microglia (2025 · Phytomedicine · 被引 11)
• Association between endocrine disrupting chemicals exposure and diabetic kidney disease in adults: A national cross-sectional NHANES study (2025 · Ecotoxicology and Environmental Safety · 被引 8)
• Discovery ofdCDK9-202 as a Highly Potent and SelectivePROTAC CDK9 Degrader with Strong In Vivo AntitumorActivity (2025 · Journal of Medicinal Chemistry · 被引 6)
• Exploiting targeted degradation of cyclins and cyclin-dependent kinases for cancer therapeutics: a review (2025 · Journal of Zhejiang University SCIENCE B · 被引 6)